YOUR SEARCH FOR Text 39 RESULTS
31 of Total
… 144: Filer Information Filer CIK 0001205703 Filer CCC XXXXXXXX Is this a LIVE or …
32 of Total
8th Annual Evercore Healthcare Conference | Incyte
Events Corporate Presentations Scientific Presentations 8th Annual Evercore Healthcare Conference Dec 3, 2025 at 1:20 PM EST Click here for Webcast
33 of Total
Medical Information Contact Info US & European Locations | Incyte.com
… medinfocanada@incyte.com Asia Japan 0120094139 jpmedinfo@incyte.com Europe +800 …
34 of Total
Incyte Involved: Unwavering Community Commitment | Incyte Stories
May 22, 2025 Incyte Involved: Unwavering Community Commitment At Incyte, our mission to Solve On . extends beyond our work and into the community.
35 of Total
Events & Presentations | Incyte
Events Corporate Presentations Scientific Presentations The information contained in prior presentation materials and webcasts should be considered
36 of Total
Contact Us | Incyte.com.com
… medinfocanada@incyte.com Asia Japan 0120094139 jpmedinfo@incyte.com Europe +800 …
37 of Total
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced An
View all news Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer December 22, 2025 at 2:42
38 of Total
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advance
View all news Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the
39 of Total
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapse
View all news Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma